Date Title Description PDF
26 Jul 2023 On buy-back programmes The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program.   Download
10 May 2023 On P&L The Company releases the first quarter 2023 financial results presentation Download
10 May 2023 On P&L The Company releases the press release related to the first quarter 2023 financial results Download
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download

Pages

Date Title Description PDF
05 Nov 2020 On business and financial situation The company releases the press release related to the 2020 first nine months financial results Download
20 Oct 2020 Announcement of general shareholders’ meeting ROVI releases the information related to its General Shareholders Meeting Download
15 Oct 2020 Announcement of general shareholders’ meeting   In view of the exceptional circumstances derived from the spread of Covid-19, the Company has agreed that the Ordinary General Meeting be held by exclusively telematic means.   Download
01 Oct 2020 Liquidity contracts and specialists Liquidity contract: transactions conducted in the third quarter of 2020 Download
11 Sep 2020 Announcement of general shareholders’ meeting Rovi releases the information related to its 2020 General Shareholders Meeting. Download

Pages

Date Title Description PDF
04 Oct 2018 Share capital increases and reductions Private placement capital increase addressed to institutional investors, excluding  preferential subscription rights Download
02 Oct 2018 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the third quarter of 2018 Download
24 Sep 2018 Others on business performance and financial information Updated information on business, financial position and risk factors Download
24 Sep 2018 Share capital increases and reductions Intention to raise gross proceeds by means of an offer addressed to institutional investors, excluding preferential subscription rights Download
26 Jul 2018 Información sobre resultados ROVI releases the 2018 first half results presentation Download

Pages